Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-09-01
Saito and colleagues established a direct three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The organoids could be propagated, cryopreserved, and converted into intestinal epithelial monolayers containing metabolically active enterocyte-like cells, supporting human-relevant studies of oral drug absorption and pharmacokinetics.
-
Safer Gel Imaging for RNA-Guided Translation
2026-09-01
A translational perspective on how Safe DNA Gel Stain can strengthen nucleic acid quality control, protect workflow integrity, and support RNA-structure-driven discovery without overstating the maturity of emerging antiviral research.
-
α2-Adrenergic Receptor Agonist: Assay Design
2026-08-31
Explore how 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine can support α2-adrenergic receptor signaling studies through a mechanism-led assay strategy. This article translates osteosarcoma recurrence findings into practical decisions about controls, readouts, formulation, and translational limits.
-
Epacadostat: From IDO1 Potency to Immune Context
2026-08-31
Epacadostat and INCB024360 are examined through a context-aware framework that connects IDO1 biochemical inhibition with whole-blood and tumor-immune readouts. Learn how to distinguish target engagement from genuine immune restoration and design more interpretable immuno-oncology assays.
-
ARCA EGFP mRNA (5-moUTP) for Assays
2026-08-30
A scenario-based guide to using ARCA EGFP mRNA (5-moUTP), SKU R1007, as a fluorescence-based transfection control in mammalian cell viability, proliferation, and cytotoxicity workflows. It connects transcript design, handling, assay controls, interpretation, and vendor-selection criteria to improve experimental comparability without overstating reporter fluorescence as a direct measure of cell health.
-
Single-Cell ERK Dynamics in Colorectal Cancer Organoids
2026-08-29
Ponsioen and colleagues combined patient-derived colorectal cancer organoids with an improved EKAREN5 FRET biosensor to measure ERK activity dynamically in individual tumor cells. Their results show that oncogenic KRAS- or BRAF-driven signaling remains strongly dependent on EGFR-mediated amplification, providing a mechanistic explanation for combining EGFR blockade with downstream MAPK-directed therapies.
-
Nicotine Signaling and Chronic Kidney Disease Progression
2026-08-28
Jain and Jaimes review clinical and experimental evidence that nicotine contributes to chronic kidney disease progression through non-neuronal nicotinic acetylcholine receptors, oxidative stress, hemodynamic changes, and pro-fibrotic signaling. The paper’s main practical contribution is a mechanistic framework for separating nicotine-related renal injury from the broader effects of cigarette smoke and for designing translational studies across disease models.
-
Entinostat (MS-275, SNDX-275) Assay Guide
2026-08-28
This scenario-based guide explains how to use Entinostat (MS-275, SNDX-275), SKU A8171, in cancer cell viability, proliferation, and cytotoxicity studies. It connects HDAC1/3 pharmacology with solvent control, time-course design, and the critical distinction between growth inhibition and cell killing.
-
Ouabain for Reliable Na⁺/K⁺-ATPase Assays
2026-08-27
This scenario-based guide shows how Ouabain (SKU B2270) can clarify cell viability, proliferation, cytotoxicity, and ion-transport experiments through a defined mechanism and practical controls. It connects assay design with cardiovascular research and senescence biology while emphasizing concentration selection, interpretation, and reagent traceability.
-
JNJ-10198409: PDGF Receptor Inhibition Workflows
2026-08-27
Build more interpretable PDGF-BB experiments with JNJ-10198409, from rapid receptor-phosphorylation assays to longer-term proliferation and angiogenesis models. This guide combines dose-design, timing controls, storage practices, and cross-domain signaling lessons to improve reproducibility without overstating translational evidence.
-
Site-Specific PEGylation of IL-11 in Lung Fibrosis
2026-08-26
The reference study engineered receptor-biased IL-11 analogs by placing a cysteine at the GP130-binding interface and selectively PEGylating it. The lead conjugates preserved IL-11Rα engagement, reduced GP130 interaction, extended systemic exposure, and attenuated bleomycin-induced pulmonary fibrosis in mice.
-
ARCA EGFP mRNA (5-moUTP): Assay Design
2026-08-26
ARCA EGFP mRNA (5-moUTP) is more than a fluorescent reporter: it is a tool for separating delivery, translation, and cell-state effects in mammalian assays. This guide combines molecular design with storage science to improve fluorescence-based transfection control and experimental reproducibility.
-
NP-40 Lysis Buffer for Neuroimmune Protein Studies
2026-08-25
Learn how a Non-denaturing lysis buffer can preserve signaling complexes while supporting Western blotting, immunoprecipitation, co-immunoprecipitation, and ELISA. This workflow translates FPR2/ALX autoimmune astrocytopathy findings into practical sample-preparation, assay-design, and troubleshooting decisions.
-
Lymphodepletion Enhances Neoantigen T Cell Therapy
2026-08-25
Sagie et al. identified the KRAS.G12V-specific TCR T104 and showed that lymphodepleting chemotherapy improves neoantigen-directed tumor killing by remodeling antigen presentation. The study connects immunoproteasome activation, increased HLA-I expression, and altered immunopeptidomes with stronger responses to TCR-T cells, tumor-infiltrating lymphocytes, and T cell engagers.
-
Pyridostatin TFA: G-Quadruplex Workflows
2026-08-24
Pyridostatin TFA provides a practical probe for connecting G-quadruplex stabilization with telomere dysfunction, cancer-cell response, and DNA-structure assays. A carefully controlled workflow can also test whether G-quadruplex modulation influences TDP-43 condensation, while keeping this emerging neurodegeneration application distinct from established telomere research.